dyslipidemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 35-50 years, permanent resident in Tianjin; 2. At least 1 compliance with diagnostic criteria for dyslipidemia (2016 Chinese Guidelines for Prevention and Treatment of Adult Dyslipidemia); 3. Have not received the lipomodulation therapy or antiplatelet therapy; 4. Without medical history of serious disease, haemostatic disorders or aspirin tolerance; 5. Voluntarily join the study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Those with familial hypercholesterolemia or secondary hyperlipidemia caused by abnormal thyroid function and nephrotic syndrome; 2. Those with diabetes mellitus, coronary heart disease; having abnormal liver and kidney function, rheumatic immune system disease, connective tissue disease, rhabdomyolysis, malignant tumor, and hematological system disease; 3. Those with communication difficulties, cognitive impairment, and mental illness; 4. Pregnant or lactating women; 5. Those with acute and chronic infection, fever, and a history of major surgery and trauma within one month prior to the start of the study; 6. Those taking statins, antiplatelet drugs, and other nutritional supplements within one month prior to the start of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| lipid profile; | — |
Secondary
| Measure | Time frame |
|---|---|
| platelet activation indicator;safety indicator;blood glucose;anthropometry indicator;cardiometabolic risk indicator;metabolites related indicator; | — |
Countries
China
Contacts
Tianjin Medical University